Syndax Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to Q3 2025.
  • Syndax Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 86.6M shares, a 1.39% increase year-over-year.
  • Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 85.6M shares, a 21.7% increase from 2023.
  • Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 70.4M shares, a 15.8% increase from 2022.
  • Syndax Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 60.8M shares, a 16.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Syndax Pharmaceuticals Inc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 86.6M +1.19M +1.39% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 86.3M +1.06M +1.25% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-04
Q1 2025 86.2M +959K +1.13% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q4 2024 85.6M +15.3M +21.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 85.4M +15.6M +22.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 85.3M +15.6M +22.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-04
Q1 2024 85.2M +15.8M +22.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q4 2023 70.4M +9.61M +15.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 69.9M +9.19M +15.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 69.6M +9.48M +15.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 69.4M +10.5M +17.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 60.8M Oct 1, 2022 Dec 31, 2022 10-K 2025-03-03
Q3 2022 60.7M +8.71M +16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 60.2M +8.55M +16.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 59M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 52M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 51.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08

Syndax Pharmaceuticals Inc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 85.6M +15.3M +21.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 70.4M +9.61M +15.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 60.8M +8.7M +16.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 52.1M +10.8M +26% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 41.3M +10.8M +35.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 30.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.